ArticleJournal of thoracic disease2025

Efficacy of the PD-1 inhibitor penpulimab in combination with chemotherapy for advanced lung squamous cell carcinoma: insights from a phase III multicenter study.

Fumihiro Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.